Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 1,045,900 | 788,100 | 451,200 | 161,626 | 15,000 |
| Cost of Goods | 10,100 | 7,400 | 4,900 | 1,254 | N/A |
| Gross Profit | 1,035,800 | 780,700 | 446,300 | 160,372 | 15,000 |
| Operating Expenses | 872,900 | 708,800 | 410,400 | 291,987 | 162,372 |
| Operating Income | 163,000 | 72,300 | 36,800 | -131,361 | -147,372 |
| Interest Expense | 32,800 | 32,000 | 30,500 | 19,523 | 0 |
| Other Income | -23,500 | 6,200 | 15,500 | 8,342 | 6,282 |
| Pre-tax Income | 106,700 | 46,500 | 21,800 | -142,542 | -141,090 |
| Income Tax | -300,600 | 9,500 | 700 | N/A | N/A |
| Net Income Continuous | 407,300 | 37,000 | 21,100 | -142,542 | -141,090 |
| Net Income | $407,300 | $37,000 | $21,100 | $-142,542 | $-141,090 |
| EPS Basic Total Ops | 4.38 | 0.40 | 0.23 | -1.62 | -1.63 |
| EPS Basic Continuous Ops | 4.37 | 0.40 | 0.23 | -1.62 | -1.63 |
| EPS Diluted Total Ops | 4.16 | 0.39 | 0.22 | -1.62 | -1.63 |
| EPS Diluted Continuous Ops | 4.16 | 0.39 | 0.22 | -1.62 | -1.63 |
| EPS Diluted Before Non-Recurring Items | 4.16 | 0.39 | N/A | N/A | N/A |
| EBITDA(a) | $193,000 | $100,000 | $59,700 | $-115,420 | $-142,399 |